E10i-494
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →
Ionizable lipid for LNP and nucleic-acid delivery research.
C9-200 is an ionizable cationic lipid that has been used in the formation of lipid nanoparticles (LNPs). LNPs containing C9-200 and encapsulating mRNA encoding erythropoietin (EPO) increase serum EPO levels in mice. LNPs containing C9-200 and encapsulating mRNA encoding the Cas9 nuclease and small-guide RNA (sgRNA) targeting transthyretin (TTR) induce 3-fold higher hepatic insertion and deletion (indel) formation than LNPs containing C12-200 and encapsulating mRNA encoding Cas9 in mice.
| CAS No. | Not available |
| Chemical Name | C9-200 |
| Synonyms | C9200, C9 200 |
| SMILES | OC(CCCCCCC)CN(CCN(CC(CCCCCCC)O)CC(CCCCCCC)O)CCN1CCN(CCN(CC(CCCCCCC)O)CC(CCCCCCC)O)CC1 |
| Formula | C55H115N5O5 |
| M.Wt | 926.5 |
| Purity | >98% |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | Not available |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 10.7933 mL | 2.1587 mL | 1.0793 mL |
| 25 mg | 26.9833 mL | 5.3967 mL | 2.6983 mL |
| 50 mg | 53.9665 mL | 10.7933 mL | 5.3967 mL |
| 100 mg | 107.9331 mL | 21.5866 mL | 10.7933 mL |
| 250 mg | 269.8327 mL | 53.9665 mL | 26.9833 mL |
Contact our team with the catalog number and requested quantity.